首页> Cancers> Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials.

Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials.

导出 OA

翻译打印收藏纠错

第一作者： Edward,Laane

第一单位： Hematology-Oncology Clinic, Tartu University, 50406 Tartu, Estonia.

作者： Edward,Laane ^[1] ; Sam,Salek ^[2] ; Esther Natalie,Oliva ^[3] ; Christine,Bennink ^[4] ; Solène,Clavreul ^[5] ; Paul G,Richardson ^[6] ; Christof,Scheid ^[7] ; Katja,Weisel ^[8] ; Tatyana,Ionova ^[9] ; European Hematology Association Specialized Working Group on Quality of Life and Symptoms

作者单位： Hematology-Oncology Clinic, Tartu University, 50406 Tartu, Estonia. ^[1] School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK. ^[2] U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, 89124 Reggio di Calabria, Italy. ^[3] Department of Hematology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands. ^[4] Myeloma Patients Europe, 1050 Brussels, Belgium. ^[5] Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA 02215, USA. ^[6] Department of Internal Medicine I, University of Cologne, 50923 Cologne, Germany. ^[7] Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. ^[8] Quality of Life Unit, Saint Petersburg State University Hospital, 190103 Saint Petersburg, Russia. ^[9]

关键词 clinical trials guideline multiple myeloma patient-reported outcomes quality of life symptoms systematic review

DOI 10.3390/cancers15245764

PMID 38136310

发布时间 2023-12-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交